Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease

Post time 3 day(s) ago

journal：Clinics and Research in Hepatology and Gastroenterology

Authors：Laya Hooshmand Gharabagh; Ali Shargh; Mohammad Reza Mohammad Hosseini Azar; Ayda Esmaeili

Published date：2024-3-

DOI：10.1016/j.clinre.2023.102279

PDF link：https://www.sciencedirect.com/sc ... 210740123002048/pdf

Article link：http://dx.doi.org/10.1016/j.clinre.2023.102279

Article Source：Elsevier BV。

Remark：

Post time 3 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Comparison between the effect of Empagliflozin and Pioglitazone added to metformin in patients with type 2 diabetes and nonalcoholic fatty liver disease